Nutrient enriched infant formula

PreclinicalSmall molecule

Nutrient enriched infant formula is one of 5 small molecule programs targeting Small for gestational age. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Small for Gestational AgeActive, not recruiting

Small for Gestational AgePreclinical

Active, not recruiting

Competition

Competitive Landscape

4 competitors in Small for Gestational Age

#DrugCompanyPhaseTrials

Somatrogon

Pfizer

Phase 3

1 2

Prometrium

Ferring

Preclinical

1 3

Growth Hormone

Pfizer

Preclinical

1 4

Recombinant Somatropin

Merck & Co.

Preclinical

1 5

Nutrient enriched infant formula

IInstitute of Child Health

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Small for gestational age1 trial

Trial of Nutritional Supplementation in Infants Born Small for Gestational Age

Completed·IInstitute of Child Health·N/A·NCT00134771

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Nutrient enriched infant formula. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Nutrient enriched infant formula compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Nutrient enriched infant formula. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Institute of Child Health company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: IInstitute of Child Health

Nutrient enriched infant formula

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Small for gestational age1 trial

References

Drug Info

Quick Facts

Related News